טוען...
Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapies
BACKGROUND: In recent years, investigators have asserted that the 3 + 3 design lacks flexibility, making its use in modern early-phase trial settings, such as combinations and/or biological agents, inefficient. More innovative approaches are required to address contemporary research questions, such...
שמור ב:
| הוצא לאור ב: | Ann Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834099/ https://ncbi.nlm.nih.gov/pubmed/28011450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw681 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|